© 2025
In touch with the world ... at home on the High Plains
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Patients turn to 'gray market' for cheaper obesity drugs, but it's risky

By Sydney Lupkin
Published October 7, 2025 at 4:05 PM CDT

Patients who want a deeper discount on obesity meds than compounding pharmacies can offer are turning to the gray market, where they buy the raw active ingredient from China and prepare it themselves.

Copyright 2025 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin